Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vaccitech Renames As Barinthus Biotherapeutics To Highlight Strategic Evolution Into A T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, And Cancer; To Trade Under New Name And Ticker 'BRNS' Effective Nov. 7

Author: Benzinga Newsdesk | November 06, 2023 10:08am

New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data

Posted In: VACC